MDT Medtronic plc
- Stocks
- Healthcare
- NYSE: MDT
Price (delayed)
$90.4
Market cap
$115.95B
P/E Ratio
24.84
Dividend/share
$2.82
EPS
$3.64
Enterprise value
$143.29B
Relative Growth:
Rel. Growth:
56
Relative Strength:
Rel. Strength:
50
Relative Valuation:
Rel. Valuation:
56
Relative Profitability:
Rel. Profitability:
78
Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around
Highlights
The EPS rose by 22% year-on-year
The price to earnings (P/E) is 20% lower than the 5-year quarterly average of 30.9 and 4.1% lower than the last 4 quarters average of 25.9
Medtronic's quick ratio has decreased by 7% YoY but it has increased by 4.2% from the previous quarter
MDT's debt is up by 2.7% year-on-year
Key stats
What are the main financial stats of MDT
Market
Valuations
Earnings
Shares outstanding
1.28B
Market cap
$115.95B
Enterprise value
$143.29B
Price to earnings (P/E)
24.84
Price to book (P/B)
2.42
Price to sales (P/S)
3.39
PEG
1.12
EV/EBIT
22.49
EV/EBITDA
15.38
EV/Sales
4.19
Revenue
$34.2B
Gross profit
$22.33B
Operating income
$6.12B
Net income
$4.66B
EBIT
$6.37B
EBITDA
$9.32B
Free cash flow
$5.3B
Per share
Balance sheet
Liquidity
EPS
$3.64
EPS diluted
$3.63
Free cash flow per share
$4.14
Book value per share
$37.38
Revenue per share
$26.69
TBVPS
$29.45
Total assets
$90.97B
Total liabilities
$42.84B
Debt
$28.61B
Equity
$47.89B
Working capital
$11.69B
Debt to equity
0.6
Current ratio
2.01
Quick ratio
1.25
Net debt/EBITDA
2.93
Margins
Efficiency
Dividend
EBITDA margin
27.2%
Gross margin
65.3%
Net margin
13.6%
Operating margin
17.9%
Return on assets
5.1%
Return on equity
9.6%
Return on invested capital
12.3%
Return on capital employed
8%
Return on sales
18.6%
Dividend yield
3.12%
DPS
$2.82
Payout ratio
77.5%
MDT stock price
How has the Medtronic stock price performed over time
Intraday
-0.02%
1 week
-1.45%
1 month
-7.47%
1 year
0.8%
YTD
13.17%
QTD
-5.08%
Financial performance
How have Medtronic's revenue and profit performed over time
Revenue
$34.2B
Gross profit
$22.33B
Operating income
$6.12B
Net income
$4.66B
Gross margin
65.3%
Net margin
13.6%
The net income has grown by 19% YoY
The operating income has increased by 19% YoY and by 2.8% QoQ
The operating margin has increased by 13% year-on-year
MDT's net margin is up by 12% year-on-year but it is down by 2.2% since the previous quarter
Price vs fundamentals
How does MDT's price correlate with its fundamentals
Growth
What is Medtronic's growth rate over time
Valuation
What is Medtronic stock price valuation
P/E
24.84
P/B
2.42
P/S
3.39
EV/EBIT
22.49
EV/EBITDA
15.38
EV/Sales
4.19
The EPS rose by 22% year-on-year
The price to earnings (P/E) is 20% lower than the 5-year quarterly average of 30.9 and 4.1% lower than the last 4 quarters average of 25.9
The stock's price to book (P/B) is 3.2% less than its 5-year quarterly average of 2.5
MDT's P/S is 15% lower than its 5-year quarterly average of 4.0
Medtronic's revenue has increased by 5% YoY
Efficiency
How efficient is Medtronic business performance
Medtronic's return on equity has increased by 23% YoY
MDT's return on assets is up by 16% year-on-year
The company's return on invested capital rose by 10% YoY
The return on sales rose by 8% year-on-year
Dividends
What is MDT's dividend history
DPS
$2.82
Dividend yield
3.12%
Payout ratio
77.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Medtronic financials performed over time
The total assets is 112% greater than the total liabilities
The company's current ratio rose by 9% QoQ but it fell by 6% YoY
Medtronic's quick ratio has decreased by 7% YoY but it has increased by 4.2% from the previous quarter
MDT's debt is 40% smaller than its equity
MDT's debt is up by 2.7% year-on-year
Medtronic's debt to equity has increased by 3.4% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.